Google and Fitbit have received clearance in the U.S.
Fitbit and parent company Google have recently announced that the United States has offered the go-ahead for their devices to automatically detect irregular AFib heart rhythms by running checks in the background. The U.S. Food and Drug Administration has approved Fitbit’s new algorithm, which means the company’s devices will soon be able to check for signs of AFib automatically without any input from the user. At this point, users themselves can already perform such checks manually using the ECG app that’s available on select Fitbit devices, such as the Sense and the Charge 5, but thanks to the new algorithm, both trackers will be able to do the whole thing on their own in the background.
